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agents need to be specifi cally targeted to tumor sites, which can 
minimize not only the laser power density but also the amount 
of  therapeutic agents. In the literature, effective photothermal 
ablation of cancer cells in vitro was readily achieved by photo-
thermal agents conjugated with targeting ligands. [ 10 ] Due to the 
high uptake in RES (reticuloendothelial) system and fast clear-
ance from blood, it still however remains a great challenge to 
enhance in vivo photothermal therapeutic effects of nanoma-
terials. [ 9–11 ] To tackle this challenge, surface modifi cation of 
polyethylene glycol (PEG) was typically introduced to achieve 
prolonged blood circulation time and lower in vivo toxicity. [ 12 ] 
For example, PEGylated graphene nanosheets exhibited very 
highly effi cient tumor passive targeting and relatively low reten-
tion in RES systems. [ 2b ] It was also reported that the geometry 
of nanomaterials played an important role in their accumula-
tion behaviors on tumor sites. [ 13 ] Graphene nanosheets were 
demonstrated to have higher accumulation in tumor tissues 
than carbon nanotubes. Besides carbon nanomaterials, how-
ever, more studies are still needed to illustrate the advantages of 
2D nanostructures for targeting tumors. 
 Recently, we have successfully synthesized ultrathin free-
standing hexagonal palladium nanosheets with well-defi ned 
thicknesses, sizes, and tunable surface plasmon resonance 
(SPR) peak in the NIR region. [ 14 ] Moreover, other noble 
metals were readily epitaxially grown on the surface of Pd 
nanosheets, [ 15 ] providing us with great opportunities to synthe-
size well-defi ned noble metal nanoplates and study their in vivo 
behaviors. With these developments, we report herein a novel 
image-guided photothermal cancer therapy platform based on 
core–shell Pd@Au nanoplates. The core–shell Pd@Au nano-
plates were synthesized by a seeded growth method using Pd 
nanosheets, with well-defi ned shapes and sizes, as seeds. The 
synthesized core–shell Pd@Au nanoplates showed strong NIR 
absorbance and excellent stability. By modifying their surface 
with thiol-polyethylene glycol (SH-PEG), the blood circula-
tion of PEGylated Pd@Au nanoplates (Pd@Au-PEG) in vivo 
was prolonged. Through passive targeting, the accumulation 
of Pd@Au-PEG in tumor site was higher than spherical Au 
nanoparticles with a similar hydrodynamic size. Using Pd@
Au-PEG as the NIR photothermal agent, photothermal ablation 
of tumors was achieved under the irradiation of 808 nm laser 
at a power density of only 0.5 W cm −2 . Their applications of the 
Pd@Au-PEG as photoacoustic (PA) and computed tomography 
(CT) contrast agent were demonstrated as well. 
 In a typical synthesis of Pd@Au core–shell nano-
plates, hexagonal Pd nanosheets with an average edge length of 
 Two-dimensional (2D) nanomaterials with a nanoscale thick-
ness have recently attracted much attention owing to their 
unique physical and chemical properties induced by the 
quantum size and surface effects. [ 1 ] For instance, graphene 
as a typical 2D nanostructure, with ultra-high specifi c sur-
face area and strong near-infrared (NIR) optical absorbance, 
has been widely applied in biomedicine and other related 
fi elds. [ 2 ] Inspired by graphene, more and more attention has 
been directed to bioapplications (e.g., photothermal therapy, 
imaging) of many other inorganic 2D nanostructures that 
exhibit excellent optical properties and biocompatibility. By 
intratumoral injection, Bi 2 Se 3 nanoplates were successfully 
applied in photothermal ablation of tumors. [ 3 ] Transition-metal 
dichalcogenides with 2D nanostructures, such as MoS 2 and 
WS 2 nanosheets, were also demonstrated as effective photo-
thermal cancer therapy agents in vitro and in vivo. [ 4 ] Despite the 
intense interest, considerable challenges remain in the devel-
opment of desirable 2D nanostructures for NIR photothermal 
therapy. In particular, few nanomaterials with well-defi ned 
thickness and diameters have been obtained using the syn-
thetic methods developed so far. [ 1a , 4a , 5 ] 
 As for photothermal cancer therapy, quite several classes 
of nanomaterials (e.g., Au nanorods, [ 6 ] nanoshells, [ 7 ] nanoc-
ages, [ 8 ] nanostars [ 9 ] that display strong absorbance and signifi -
cant photothermal effect in the NIR region have been widely 
explored in the past decade. However, to make them highly 
effective for therapeutic purpose, photothermal therapeutic 
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≈15 nm and a thickness of 1.8 nm were fi rst synthesized (see the 
Experimental Section for details; Figure S1, Supporting 
Information) and used as seeds for the formation of bimetallic 
Pd@Au nanoplates ( Figure  1 a). The overgrowth of Au on Pd 
nanosheets was achieved by chemically reducing AuPPh 3 Cl 
with hydrazine hydrate in  N , N -dimethylformamide, with a Au/
Pd mole ratio of 10:1. The obtained Pd@Au nanoplates exhib-
ited a deep aquamarine color in aqueous solution (Figure  1 c). 
As shown in the representative transmission electron micros-
copy (TEM) image of the as-made core–shell Pd@Au nanoplates 
(Figure  1 b), the nanoplates still adopted a hexagonal plate-like 
shape and had a mean diameter of ≈30 nm, similar to that of Pd 
nanosheet seeds. However, the average thickness of the Pd@
Au nanosheets was ≈4 nm, larger than that of Pd nanosheets. 
As illustrated in the high-resolution TEM (HRTEM) image 
(Figure  1 d), the core–shell Pd@Au nanoplates were highly 
crystalline. Well-defi ned lattice fringes with d-spacing of 2.3 Å 
corresponding to the {111} planes of Au were clearly observed. 
Moreover, the elemental distribution of Au on Pd nanosheets 
was studied by energy-dispersive X-ray (EDX) spectroscopy. 
Both the elemental-mapping analysis (Figure  1 e) and the EDX 
line profi le (Figure  1 f) revealed that both Au and Pd atoms were 
homogeneously distributed throughout the as-prepared core–
shell Pd@Au nanoplates, suggesting that Au was successfully 
epitaxially overgrown on the Pd nanosheets. 
 As previously reported, [ 14–16 ] the SPR properties of 2D metal 
nanostructures are tunable depending on their diameter and 
thickness. Herein, by changing the sizes of Pd nanosheet seeds, 
different-sized Pd@Au nanoplates with SPR peaks ranging 
from 600 nm to 1300 nm (Figure S1, Supporting Information) 
were readily prepared. As shown in Figure  1 f, with an average 
diameter of 30 nm and thickness of 4 nm, the as- prepared Pd@
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 Figure 1.  Synthesis and characterizations of Pd@Au nanoplates. a) Scheme shows the fabrication process of Pd@Au nanoplates. b) Representative 
TEM image. c) Photograph of a water dispersion of the as-prepared Pd@Au nanoplates. d) HRTEM image of a Pd@Au nanoplate fl at lying on the TEM 
grid. e) HAADF-STEM image and EDX mapping images of a Pd@Au nanoplate. f) EDX line profi les of the Pd@Au nanoplate as shown in the left inset 
HAADF-STEM image. g) UV-Vis-NIR absorption of Pd@Au nanoplates with different concentrations. h) Temperature rise curves of Pd@Au nanoplates 
with different concentrations upon 0.5 W cm −2 808 nm laser irradiation.











N Au nanosheets dispersed in water exhibited a strong absorp-
tion with a peak centered at 700 nm but extended into the NIR 
region. To demonstrate the potential of Pd@Au nanoplates as 
an NIR photothermal therapy agent, the photothermal effect 
of Pd@Au nanoplates was investigated by monitoring the tem-
perature increase of 1 mL aqueous solution containing Pd@
Au nanoplates at different concentrations upon NIR irradia-
tion. Under a given laser power, the temperature increase is 
determined by the concentration of the photothermal agent 
and the irradiation time as well. Experimentally, we examined 
the temperature changes during the course of 10 min irradia-
tion by the 808 nm laser with a power density of 0.5 W cm −2 . 
As shown in Figure  1 g, while the control experiment using 
pure water gave a temperature increase of less than 2 °C, the 
temperature of the solution containing 50 ppm Pd@Au was 
increased by up to 15 °C in 10 min irradiation. According to 
the previous reported method, [ 17 ] the photothermal conversion 
effi ciency of Pd@Au-PEG was calculated to be 28.6%, which is 
comparable to that of gold nanorods (22%) and gold nanoshells 
(13%). Moreover, Pd@Au-PEG exhibited excellent stability in 
different media at 37 °C, and the absorbance at 808 nm did not 
change under laser irradiation (808 nm, 0.5 W cm −2 ) for 30 min 
(Figures S2 and S3, Supporting Information). 
 As measured by dynamic light scattering (DLS), the Pd@
Au-PEG in aqueous solution showed a hydrodynamic size of 
≈60 nm (Figure S4a, Supporting Information), larger than the 
size measured by TEM. The measurement of zeta potential 
indicated that the Pd@Au-PEG was nearly neutrally charged 
(Figure S4b, Supporting Information). It has been well docu-
mented that the surface modifi cation by long-chained PEG 
molecules helps nanoparticles to escape from macrophage 
clearance in reticuloendothelial systems (RES) and thus pro-
long their circulation time in the blood. Consequently, their 
passive targeting to tumor sites can be enhanced. [ 18 ] The blood 
circulation of Pd@Au-PEG was thus studied to probe their in 
vivo behaviors. Experimentally, Balb/c mice were intravenously 
injected with Pd@Au-PEG at a dose of 15 mg kg −1 (300 µL of 
1 mg mL −1 solution). Tail blood was drawn at different times 
and digested to measure the amount of Au in blood by induc-
tively coupled plasma mass spectrometry (ICP-MS). As shown 
in  Figure  2 a, the blood circulation half-life time was as long as 
8 h, allowing them to be passively targeted more to tumor sites. 
 To further study the in vivo biodistribution of Pd@Au-PEG, 
Balb/c mice bearing 4T1 murine breast cancer tumors were 
intravenously injected with Pd@Au-PEG at a dose of 15 mg kg −1 
(300 µL, 1 mg mL −1 ). The mice were then sacrifi ced at 1, 12, 
and 24 h after injection. Major organs and tissues (i.e., liver, 
tumor, heart, kidney, lung, spleen, skin, brain, stomach, and 
bone) were weighted and digested to determine the amounts 
of Au using ICP-MS. Surprisingly, as shown in Figure  2 b, the 
highest accumulation of Pd@Au-PEG was revealed in tumors. 
The accumulations of Au in tumor sites were measured to be 
≈2% ID g −1 , ≈15% ID g −1 , and ≈79% ID g −1 as the postinjection 
time was increased from 1 h, 12 h to 24 h. In comparison, the 
accumulations of Pd@Au-PEG in the liver and spleen were rel-
atively low. After 24 h, the accumulations in the liver and spleen 
were ≈17% ID g −1 and ≈33% ID g −1 , respectively. The high 
accumulation of Pd@Au-PEG in tumor sites was attributed to 
the enhanced permeability and retention (EPR) effect due to 
the tortuous and leaky nature of tumor vasculature. Besides 
the surface PEGylation, the unique 2D structural feature of 
Pd@Au nanoplates was critical to enhance their passive accu-
mulation in tumors. For comparison, spherical Au nanoparticles 
with a similar size to that of Pd@Au-PEG were synthesized. [ 19 ] 
The accumulation of PEGylated spherical Au nanoparticles in 
tumor sites was measured to be only ≈19% ID g −1 at 24 h, much 
less than that of Pd@Au-PEG (Figure S5, Supporting Infor-
mation). This result clearly demonstrated the importance of 
2D morphology of Pd@Au nanoplates in enhancing their bio-
distribution for imaging and therapeutic purposes. 
 PA imaging is a newly developed and hybrid biomedical 
imaging modality that measures the ultrasonic waves induced 
by tissues’ absorption (e.g., hemoglobin and melanin) of pulsed 
laser. [ 20 ] However, many diseases do not manifest an endog-
enous PA contrast due to their weak optical absorption. It is 
thus essential to develop exogenous PA contrast agents with 
excellent photothermal effect to convert NIR light into heat 
for acoustic imaging. [ 21 ] To demonstrate the PA imaging prop-
erties of Pd@Au-PEG, in vitro PA imaging was performed in 
vials using a PA instrument at the wavelengths of 700 nm. As 
shown in Figure S6 (Supporting Information), Pd@Au-PEG 
exhibited signifi cant PA contrast effect, which motivated us to 
use PA imaging to visualize the in vivo accumulation behavior 
of Pd@Au-PEG with high spatial resolution and anatomical 
localization. Without the need to sacrifi ce mice, in this work, 
the PA imaging method allowed us to verify the high accumula-
tion of Pd@Au-PEG in tumor sites as monitored by ICP-MS 
measurements. Experimentally, PA images of tumors with no 
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 Figure 2.  In vivo experiments of Pd@Au-PEG. a) Blood circulation curve 
of Pd@Au-PEG as determined by measuring the Au amount in blood 
at different time. b) Biodistribution of Pd@Au-PEG in different organs 
at 1, 12, and 24 h p.i. Error bars were based on 3–5 mice per point.











treatment were fi rstly recorded. Pd@Au-PEG was then intrave-
nously injected at a dose of 15 mg kg −1 (300 µL, 1 mg mL −1 ). 
PA images were recorded at 1, 6, 12, and 24 h postinjection. 
As shown in  Figure  3 , only major blood vessels could be 
observed without Pd@Au-PEG. After the injection, the values 
of PA signals in tumor sites increased and the outline of tumor 
became much clear as time went on, indicating the gradual 
accumulation of Pd@Au-PEG in the tumor. The PA signals 
were more than four times enhanced after 24 h injected with 
Pd@Au-PEG. It should be pointed out that the accumulation 
behavior of Pd@Au-PEG observed by the in vivo PA imaging 
was consistent to that measured by ICP-MS. 
 X-ray CT is one of the most useful diagnostic tools in hos-
pitals in terms of frequency of use and cost. [ 22 ] The use of Au 
nanoparticles as CT contrast agents has received considerable 
attention for their high X-ray absorption, good biocompatibility, 
and easy surface modifi cation. [ 23 ] To assess the potential of Pd@
Au-PEG as an effective CT contrast agent, the X-ray attenuation 
of Pd@Au-PEG with different concentrations was evaluated. As 
shown in  Figure  4 a,b, the CT signal intensity indeed increased 
with the concentration of Au. CT values and Pd@Au-PEG con-
centration displayed a well-correlated linear relationship. The 
good CT imaging performance of Pd@Au-PEG in vitro moti-
vated us to further use Pd@Au-PEG for in vivo CT imaging. As 
shown in Figure  4 c, the tumor CT images were obtained before 
and 24 h after intravenously injection of Pd@Au-PEG. The 
tumor site showed an obvious enhancement with a signifi cantly 
higher CT value 24 h postinjection as shown in Figure  4 d, which 
is again an evidence for the high accumulation in tumor sites. 
 Based on the above two types of imaging techniques, an 
image-guided photothermal therapy was carried out to inves-
tigate its cancer therapy application in vivo using 4T1 tumor 
model on Balb/c mice. Ten mice bearing 4T1 tumor at their 
right shoulder were intravenously injected with 300 µL of Pd@
Au-PEG at 1 mg mL −1 (a dose of 15 mg kg −1 ). Another 10 mice 
without Pd@Au-PEG injection were used as the control. As dis-
cussed above, the accumulation of Pd@Au-PEG in tumor sites 
was relatively high at 24 h postinjection. It is worth mentioning 
that the color of tumors on the mice injected with Pd@Au-PEG 
turned black at 24 h postinjection ( Figure  5 d). Interestingly, 
Pd@Au nanoplates could be observed by TEM measurements 
on the ultrathin section tumor samples (Figure S7, Supporting 
Information). Based on these results, we therefore treated the 
tumors with 808 nm laser at a power density of 0.5 W cm −2 at 
24 h postinjection. As illustrated in Figure  5 a and Figure S8 
(Supporting Information), the surface temperature of tumors 
on Pd@Au-PEG-injected mice reached ≈60 °C only after 
4 min laser irradiation. In comparison, less than 3 °C of sur-
face temperature increase was observed for irradiated tumors 
on uninjected mice. Another two control groups of mice with 
and without Pd@Au-PEG injection were not irradiated. Tumor 
sizes were measured every other day after treatment. As 
shown in Figure  5 b–d, all irradiated tumors on mice injected 
with Pd@Au-PEG disappeared after laser irradiation and no 
tumor regrowth was noted in this treated group over a course 
of 60 d. In marked contrast, tumors in the control untreated 
group, the irradiation only group (no Pd@Au-PEG injection), 
and the Pd@Au-PEG only group (no laser irradiation) showed 
relatively rapid tumor growth, demonstrating that the NIR laser 
irradiation or Pd@Au-PEG injection by itself did not affect the 
tumor development. Mice in these three control groups showed 
average life spans of no more than ≈20 d, while mice in the 
treated group were tumor-free after treatment (Pd@Au-PEG 
injection, NIR laser irradiation) and survived over 60 d without 
a single death, further demonstrating the excellent effi cacy of 
Pd@Au-PEG-based in vivo photothermal therapy. 
 Considering that the toxicity effects are always a concern for 
nanoparticles used in the fi eld of biology, we fi nally examined 
the potential in vivo toxicity of Pd@Au-PEG. In this work, we 
did not notice any obvious sign of toxic side effects for Pd@
Au-PEG-injected mice at the dose of 15 mg kg −1 within 60 d 
and 1 year. Neither death nor signifi cant body weight drop was 
noted in the Pd@Au-PEG + laser-treated group (Figure S9a, 
Supporting Information). Major organs of Pd@Au-PEG-treated 
mice whose tumors were eliminated by the photothermal 
therapy were collected 60 d and even 1 year after the treatment 
for histology analysis. No noticeable signal of organ damage 
was observed from hematoxylin and eosin (H&E) stained organ 
slices (Figure S9b, Supporting Information), suggesting the 
promise of using Pd@Au-PEG for in vivo applications. 
 In conclusion, we have demonstrated the use of core–shell 
Pd@Au-PEG as a multifunctional platform as imaging con-
trast agents and effective hyperthermia agent for photothermal 
cancer therapy. Using a seeded growth method, Pd@Au nano-
plates were synthesized utilizing Pd nanosheets as the seed 
and AuPPh 3 Cl as the Au precursor. When surface modifi ed 
with SH-PEG, Pd@Au-PEG exhibited an excellent performance 
in physiological environments with a relatively long blood 
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 Figure 3.  Photoacoustic imaging of Pd@Au-PEG in tumor sites and 
quantifi cation photoacoustic signals of tumor site at different time.
 Figure 4.  a) In vitro CT attenuation (HU) plot and b) CT images of 
Pd@Au-PEG with different concentrations. c) In vivo cross-sectional CT 
images and d) CT values of mice before and after Pd@Au-PEG.












circulation half-life time. Moreover, a surprisingly high accumula-
tion of Pd@Au-PEG in tumor sites was achieved due to the high 
passive targeting by EPR effect and relatively low uptake by RES 
system such as the liver and spleen. The potential of Pd@Au-PEG 
as imaging contrast agents for both PA imaging and CT imaging 
was successfully demonstrated. With a high accumulation in 
tumor sites, photothermal cancer therapy was achieved using 
808 nm laser with a power density of 0.5 W cm −2 , much lower 
than that for most reported photothermal agents. These results 
suggest Pd@Au-PEG as a promising theranostic agent for cancer 
treatment. The study provides new evidence for the superiority 
of 2D nanostructures for in vivo biomedical applications. Consid-
ering the presence of Pd in the core of Pd@Au nanoplates, more 
studies are, however, needed to evaluate their long-term safety. 
 Experimental Section 
 Reagents : Pd(acac) 2 (99%) was purchased from Alfa Aesar,  N , N -
dimethylacetamide,  N , N -Dimethylpropionamide, purchased from Alfa 
Aesar. Tetrabutylammonium bromide, poly(vinylpyrrolidone) (PVP) 
(molecular weight (MW) = 30 000 g mol −1 )  N , N -dimethylformamide, 
NaBr, and N 2 H 4 (hydrazine) were purchased from 
Sinopharm Chemical Reagent Co. Ltd. (Shanghai, 
China). The water used in all experiments was 
ultrapure (18.2 MΩ). All reagents were used as 
received without further purifi cation. 
 Synthesis of Pd Nanosheets : Pd(II) acetylacetonate 
(Pd(acac) 2 , 10.0 mg), PVP (32.0 mg), and 
NaBr (10.2 mg) were mixed together with  N , N -
dimethylacetamide (2 mL) and water (4 mL) 
in a glass pressure vessel. The vessel was then 
charged with CO to 1 bar and heated from room 
temperature to 60 °C in 0.5 h, and then kept at 
60 °C for another 2.5 h before it cooled to room 
temperature. Then Pd(acac) 2 (37.5 mg) was 
added to the as-synthesized seeds solution and 
charged with CO to 1 bar. The mixture was heated 
from room temperature to 60 °C in 1 h, and then 
kept at 60 °C for another 1 h before it cooled 
to room temperature. The dark blue products 
were precipitated by acetone, separated via 
centrifugation, and further purifi ed by an ethanol–
acetone mixture. 
 Synthesis of Pd@Au Nanoplates : For a typical 
synthesis of Pd@Au core–shell nanoplates, Pd 
nanosheets synthesized above and AuPPh 3 Cl 
(10 mg mL −1 in  N , N -dimethylformamide) were 
mixed together in  N , N -dimethylformamide to give 
a molar ratio of Au: Pd of ≈10. Then hydrazine 
was added dropwise while the mixture was stirred. 
After all the above were done, the solution was left 
undisturbed at room temperature for more than 
12 h. The products were precipitated by acetone, 
separated via centrifugation, and further purifi ed by 
an ethanol–acetone mixture. 
 Characterization : TEM studies were performed 
on a TECNAI F-30 high-resolution transmission 
electron microscope operating at 300 kV. The 
samples were prepared by dropping ethanol 
dispersion of samples onto 300-mesh carbon-
coated copper grids and immediately evaporating 
the solvent. All the UV-Vis-NIR absorption spectra 
were taken on a Cary 5000 Scan UV-Vis-NIR 
spectrophotometer (Varian) using water as the 
solvent. 
 Xenograft Tumor Mouse Model with Tumor Cells : Female Balb/c mice 
(weight ≈20 g) were obtained from Shanghai SLAC laboratory Animal Co., 
Ltd. and all the experiments were carried out under protocols approved 
by Xiamen University Laboratory Animal Center. The 4T1 murine breast 
tumor models were generated by subcutaneous injection of 5 × 10 6 cells 
in ≈50 µL phosphate buffer solution (PBS) onto the right rear fl anks of 
each mouse. 
 Photothermal Therapy In Vivo Using NIR Laser : The photothermal 
therapy in vivo was carried out by using an optical fi ber-coupled 
808 nm high power laser diode (BWT Beijing Co., Ltd.). Experimentally, 
the tumor on each mouse was exposed to the 808 nm NIR laser with 
a power density of 0.5 W cm −2 for 4 min. Then, the tumor sizes were 
measured by a caliper every other day and calculated as the volume = 
(tumor length) × (tumor width) 2 /2. Relative tumor volumes were defi ned 
as the tumor change during the experiment, which were calculated as 
 V / V 0 ( V 0 was the initiated tumor volume when the treatment started, 
while  V was the tumor volume during the treatment). 
 In Vivo NIR Imaging : To image the temperature of tumors when they 
were exposed to laser, an infrared thermography (HM-300, Guangzhou 
SAT Infrared Technology Co., Ltd.) was used to capture the temperature 
change on the sites of the tumors. 
 In Vivo PA Imaging : PA imaging was performed using Nexus 128 
scanner manufactured by Endra Life Sciences (Ann Arbor, MI, USA). 
700 nm were chosen as the working laser wavelength with 30 pulses 
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 Figure 5.  a) Infrared thermal images of tumor-bearing mice with and with no Pd@Au-PEG 
injection under 0.5 W cm −2 808 nm laser. b) Relatively tumor volume of different group. Rela-
tive tumor volumes were normalized to their initial sizes. c) Survival rate curves of different 
groups. d) Representative photographs of mice with Pd@Au-PEG injection and photothermal 
cancer therapy. The tumor color was obviously blacker 24 h after Pd@Au-PEG injection, which 
was also an evidence for the high accumulation of Pd@Au-PEG in tumor sites.
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averaging. During the scanner, the water heating system maintains the 
water temperature at 38 °C to keep the mice comfort. PA scans were 
performed before the injection of the contrast agent. Then, Pd@Au 
nanoplates were injected into the mouse tail vein and the PA imaging 
was performed at different time. 
 In Vitro and In Vivo CT Imaging : CT imaging was acquired using 
Mediso nanoScan SPECT/CT produced by Mediso Ltd. Imaging 
parameters were as follows: slice thickness, medium; tube energy, 
50 kVp, 670 µA; CTDIvol, 7279.9cGy; semicircular parameters, full scan; 
Number of projections, 480; In-plane voxel size, medium. All animals 
were scanned in the cranial to caudal direction from the lower chest to 
the pelvis. CT data were analyzed using the Hounsfi eld units (HU) for 
regions. 
 Biodistribution of Pd@Au Nanoplates : After injected with 300 µg Pd@
Au nanoplates, the mice were sacrifi ced at 1, 12, and 24 h to obtain the 
major organs. At every point, there were 3–6 mice sacrifi ced. Then the 
organs were dissected and weighed for distribution studies. ICP-MS was 
used to measure the quantity of Au. 
 TEM Observation of Tumors : TEM was used to determine the 
location and uptake of Pd@Au nanoplates in tumor sites. Tumors 
of Pd@Au-injected mice were fi xed in 2.5% glutar-aldehyde, 1% 
paraformaldehyde in 0.1 M PBS solution at 4 °C. Samples were then 
rinsed with PBS solution, post fi xated with 1% osmium tetroxide in 
PBS solution at 4 °C for 1 h and rinsed with distilled water, dehydrated 
through a graded ethanol and acetone series, and infi ltrated in 
Spurr’s resin. Samples were then embedded in pure Spurr’s resin and 
polymerized for 24 h at 60 °C. Ultrathin sections of ≈70–100 nm were 
cut with Leica UC6 and transferred to 200-mesh TEM grids. Sections 
were lightly stained with uranyl acetate and lead citrate and viewed on a 
JEOL 1400 TEM operating at 100 kV accelerating voltage. 
 Histology Examination : Sixty days and 1 year after the injection of 
Pd@Au nanoplates, major organs from the treatment group and age-
matched female Balb/c control mice (without any tumor and injection 
of Pd@Au nanoplates) were harvested and fi xed in 10% neutral buffered 
formalin, processed routinely into paraffi n, sectioned at 10 microns, 
stained with H&E, and examined by a digital microscope. Tissues that 
were examined include the liver, kidneys, spleen, heart, and lung. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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